NasdaqGM:RDNTHealthcare
Does Raymond James’ Reaffirmed Strong Buy Amid Short-Seller Scrutiny Change The Bull Case For RadNet (RDNT)?
Earlier this month, Raymond James reiterated its Strong Buy rating on diagnostic imaging provider RadNet, signaling continued confidence in the company despite recent scrutiny of its AI segment and accounting practices.
This endorsement arrived shortly after a short-seller report questioned RadNet’s AI-driven growth and insider selling, putting the company’s digital health narrative under closer investor review.
We’ll now examine how Raymond James’ reaffirmed confidence, despite the...